Why the study?
Does intravenous verapamil alter atrial electrophysiological properties in patients with paroxysmal atrial fibrillation?
Does intravenous verapamil alter atrial electrophysiological properties in patients with paroxysmal atrial fibrillation?
Intravenous verapamil prolongs intraatrial conduction delay and increases fragmented atrial activity, potentially favoring the production of atrial reentry in patients with paroxysmal AF.
No takes yet. Share an insight, caveat, or question.
May promote atrial reentry substrates in paroxysmal AF; single case report leaves open clinical relevance and need for controlled trials.
Kumagai et al. (1993) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: